The BiDil pill, which combines two drugs to treat a type of heart failure, reportedly with greater success among blacks than whites, has become controversial as ethicists debate the issue. Some say there is no evidence blacks fare better with treatment than whites, as researchers plan to reveal next week the results of a major trial involving only black participants.

Related Summaries